Condensed Consolidated Statement of Changes in Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Noncontrolling Interest [Member]	Total
Balance - December 31, 2020 at Dec. 31, 2020	$ 2,537	$ 64	$ 87,570	$ (88,275)		$ (2,369)	$ (473)
Balance, shares at Dec. 31, 2020	1,228,075	63,819,935
Series B Convertible Preferred Stock dividends declared	$ 72			(72)
Dividends declared - Series B Convertible Preferred Stock, shares	24,198
Issue common stock – exercise Series Z warrants		$ 1	1,375				1,376
Issue common stock - exercise Series Z warrants, shares		860,217
Exercise - stock options			80				80
Exercise - stock options, shares		80,000
Issue common stock - Employee Stock Purchase Plan			304				304
Purchase - Employee Stock Purchase Plan, shares		203,480
Stock-based compensation - PAVmed Inc. 2014 Equity Plan			631				631
Stock-based compensation - majority-owned subsidiary			3			802	805
Net Loss				(9,431)		(679)	(10,110)
Issue common stock – registered offerings, net		$ 16	53,688				53,704
Issue common stock - registered offerings, net, shares		15,782,609
Issue common stock upon partial conversions of Senior Secured Convertible Note			1,723				1,723
Issue common stock upon partial conversions of Senior Secured Convertible Note, shares		667,668
Issue common stock – conversion Series B Convertible Preferred Stock	$ (22)		22
Conversions - Series B Convertible Preferred Stock, shares	(10,835)	10,835
Balance - March 31, 2021 at Mar. 31, 2021	$ 2,587	$ 81	145,396	(97,778)		(2,246)	48,040
Balance, shares at Mar. 31, 2021	1,241,438	81,424,744
Balance - December 31, 2020 at Dec. 31, 2021	$ 2,419	$ 86	198,071	(138,910)		17,752	79,418
Balance, shares at Dec. 31, 2021	1,113,919	86,367,845
Series B Convertible Preferred Stock dividends declared	$ 67			(67)
Dividends declared - Series B Convertible Preferred Stock, shares	22,291
Restricted stock awards vestings
Vest - restricted stock awards vests, shares		466,666
Issue common stock – exercise Series Z warrants
Issue common stock - exercise Series Z warrants, shares		5
Exercise - stock options		$ 1	241				242
Exercise - stock options, shares		237,499
Exercise - stock options of majority-owned subsidiary						187	187
Issue common stock - Employee Stock Purchase Plan			217				217
Purchase - Employee Stock Purchase Plan, shares		194,240
Impact of subsidiary equity transactions			(87)			87
Stock-based compensation - PAVmed Inc. 2014 Equity Plan			1,277				1,277
Stock-based compensation - majority-owned subsidiary						3,537	3,537
Treasury stock					(512)		(512)
Treasury stock, shares		(354,609)
Net Loss				(16,872)		(2,761)	(19,633)
Balance - March 31, 2021 at Mar. 31, 2022	$ 2,486	$ 87	$ 199,719	$ (155,849)	$ (512)	$ 18,802	$ 64,733
Balance, shares at Mar. 31, 2022	1,136,210	86,911,646